Evolution of Complex Target SELEX to Identify Aptamers against Mammalian Cell-Surface Antigens.

Evolution of Complex Target SELEX to Identify Aptamers against Mammalian Cell-Surface Antigens.
复制标题

复杂靶标SELEX的演变以鉴定针对哺乳动物细胞表面抗原的适体。

DOI:
10.3390/molecules22020215
复制
发表时间:
2017-01-30
期刊:
Molecules (Basel, Switzerland)
影响因子:
--
通讯作者:
Mallikaratchy P
Mallikaratchy P
中科院分区:
其他
文献类型:
--
作者:
Mallikaratchy P

文献摘要

参考文献

被引文献

相似文献

对具有改进的检测限的复杂分子工具的需求已经增加。这样的分子应该结构简单,但对于临床应用来说足够稳定。核酸适体(NAAs)代表了能够满足这种需求的一类分子。特别地,适体,一类由单链修饰/未修饰的RNA/DNA分子组成的小核酸配体,可以使用针对几乎任何分子的指数富集配体系统进化(SELEX)从复杂文库进化。自1990年引入以来,SELEX技术本身经历了几次修改,改进了选择并扩大了目标库。这篇综述总结了这些推动该领域向前发展的里程碑,使研究人员能够生成可作为治疗和诊断试剂的适体。
The demand has increased for sophisticated molecular tools with improved detection limits. Such molecules should be simple in structure, yet stable enough for clinical applications. Nucleic acid aptamers (NAAs) represent a class of molecules able to meet this demand. In particular, aptamers, a class of small nucleic acid ligands that are composed of single-stranded modified/unmodified RNA/DNA molecules, can be evolved from a complex library using Systematic Evolution of Ligands by EXponential enrichment (SELEX) against almost any molecule. Since its introduction in 1990, in stages, SELEX technology has itself undergone several modifications, improving selection and broadening the repertoire of targets. This review summarizes these milestones that have pushed the field forward, allowing researchers to generate aptamers that can potentially be applied as therapeutic and diagnostic agents.
DOI: 10.1038/nbt.1560
发表时间: 2009-09
影响因子: 46.9
作者:
Dassie, Justin P.;Liu, Xiu-ying;Thomas, Gregory S.;Whitaker, Ryan M.;Thiel, Kristina W.;Stockdale, Katie R.;Meyerholz, David K.;McCaffrey, Anton P.;McNamara, James O., II;Giangrande, Paloma H.
通讯作者: Giangrande, Paloma H.
DOI: 10.1371/journal.pone.0015004
发表时间: 2010-12-07
期刊: PloS one
影响因子: 3.7
作者:
Gold L;Ayers D;Bertino J;Bock C;Bock A;Brody EN;Carter J;Dalby AB;Eaton BE;Fitzwater T;Flather D;Forbes A;Foreman T;Fowler C;Gawande B;Goss M;Gunn M;Gupta S;Halladay D;Heil J;Heilig J;Hicke B;Husar G;Janjic N;Jarvis T;Jennings S;Katilius E;Keeney TR;Kim N;Koch TH;Kraemer S;Kroiss L;Le N;Levine D;Lindsey W;Lollo B;Mayfield W;Mehan M;Mehler R;Nelson SK;Nelson M;Nieuwlandt D;Nikrad M;Ochsner U;Ostroff RM;Otis M;Parker T;Pietrasiewicz S;Resnicow DI;Rohloff J;Sanders G;Sattin S;Schneider D;Singer B;Stanton M;Sterkel A;Stewart A;Stratford S;Vaught JD;Vrkljan M;Walker JJ;Watrobka M;Waugh S;Weiss A;Wilcox SK;Wolfson A;Wolk SK;Zhang C;Zichi D
通讯作者: Zichi D
DOI: 10.1038/mtna.2016.73
发表时间: 2016-09-20
期刊: Molecular therapy. Nucleic acids
影响因子: --
作者:
通讯作者: --
适体介导的siRNA传递。
DOI: 10.1093/nar/gkl388
发表时间: 2006-06-01
影响因子: 14.9
作者:
Chu, Ted C.;Twu, Karen Y.;Ellington, Andrew D.;Levy, Matthew
通讯作者: Levy, Matthew
DOI: 10.1016/j.ophtha.2006.02.064
发表时间: 2006-09-01
期刊: OPHTHALMOLOGY
影响因子: 13.7
作者:
Chakravarthy, U.;Adamis, A. P.;Patel, Manju
通讯作者: Patel, Manju